GDNF and Parkinson disease: For example, glial-cell-line-derived neurotrophic factor (GDNF) is the most studied NTF in the context of Parkinson’s disease (PD); already, six clinical trials on GDNF in PD patients have been conducted starting from the early 2000s [1].